Our finding that an augmentation of the PD-1 pathway leads to a worse prostate cancer prognosis may indicate that tumor immune escape, and thus tumor immune elimination, are important mechanisms in prostate cancer. The gene discussed is PDCD1; the disease is prostate cancer.